Danaher Co. (NYSE:DHR) Stock Position Lowered by Fifth Third Bancorp

Fifth Third Bancorp trimmed its position in shares of Danaher Co. (NYSE:DHR) by 0.1% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 522,526 shares of the conglomerate’s stock after selling 522 shares during the period. Fifth Third Bancorp owned 0.07% of Danaher worth $119,946,000 at the end of the most recent reporting period.

Several other large investors also recently added to or reduced their stakes in DHR. Eclectic Associates Inc. ADV boosted its position in Danaher by 8.7% during the 4th quarter. Eclectic Associates Inc. ADV now owns 964 shares of the conglomerate’s stock worth $221,000 after acquiring an additional 77 shares during the period. CX Institutional boosted its holdings in shares of Danaher by 2.1% during the fourth quarter. CX Institutional now owns 2,970 shares of the conglomerate’s stock worth $682,000 after purchasing an additional 62 shares during the period. Manitou Investment Management Ltd. grew its position in Danaher by 0.5% during the fourth quarter. Manitou Investment Management Ltd. now owns 92,685 shares of the conglomerate’s stock valued at $21,276,000 after purchasing an additional 481 shares in the last quarter. Hengehold Capital Management LLC increased its stake in Danaher by 30.3% in the 4th quarter. Hengehold Capital Management LLC now owns 2,340 shares of the conglomerate’s stock valued at $537,000 after buying an additional 544 shares during the period. Finally, True North Advisors LLC boosted its stake in shares of Danaher by 70.8% during the 4th quarter. True North Advisors LLC now owns 1,720 shares of the conglomerate’s stock valued at $395,000 after buying an additional 713 shares during the period. 79.05% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

DHR has been the subject of a number of research reports. Evercore ISI lifted their price objective on Danaher from $275.00 to $278.00 and gave the company an “outperform” rating in a research report on Tuesday, October 1st. Robert W. Baird reduced their target price on shares of Danaher from $278.00 to $277.00 and set an “outperform” rating for the company in a research note on Wednesday, October 23rd. Bank of America upgraded shares of Danaher from a “neutral” rating to a “buy” rating and set a $290.00 price target on the stock in a research note on Friday, December 13th. Barclays decreased their price objective on shares of Danaher from $285.00 to $275.00 and set an “equal weight” rating for the company in a report on Wednesday, October 23rd. Finally, Stephens reaffirmed an “overweight” rating and issued a $315.00 price target on shares of Danaher in a research report on Wednesday, October 23rd. Six equities research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. According to data from MarketBeat, Danaher has an average rating of “Moderate Buy” and an average target price of $285.55.

Danaher Stock Up 0.1 %

DHR opened at $245.95 on Friday. The company has a market capitalization of $177.65 billion, a P/E ratio of 46.94, a P/E/G ratio of 4.43 and a beta of 0.83. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.37 and a quick ratio of 1.01. The firm’s fifty day moving average price is $235.02 and its two-hundred day moving average price is $253.41. Danaher Co. has a fifty-two week low of $225.42 and a fifty-two week high of $281.70.

Danaher (NYSE:DHR) last posted its quarterly earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.57 by $0.14. Danaher had a net margin of 16.39% and a return on equity of 10.62%. The firm had revenue of $5.80 billion during the quarter, compared to analyst estimates of $5.59 billion. During the same quarter in the prior year, the business posted $2.02 earnings per share. The company’s quarterly revenue was up 3.1% compared to the same quarter last year. On average, analysts anticipate that Danaher Co. will post 7.5 EPS for the current year.

Danaher Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Friday, December 27th will be given a dividend of $0.27 per share. The ex-dividend date of this dividend is Friday, December 27th. This represents a $1.08 annualized dividend and a dividend yield of 0.44%. Danaher’s dividend payout ratio (DPR) is presently 20.61%.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.